501: CH Systemic Lupus Erythematosus: Biologic Combination Therapies for the Treatment of Lupus Nephritis

Community Speaker(s)

• 

  Maria Dall'Era, MD

  Director
  UCSF
  Corte Madera, CA, United States

  Disclosure(s): Amgen: Consultant (Ongoing); AstraZeneca: Consultant (Terminated, May 1, 2022); Aurinia: Consultant (Ongoing); BMS: Consultant (Ongoing); GlaxoSmithKline (GSK): Consultant (Ongoing)

Hub Host(s)

• 

  Karen Costenbader, MD, MPH

  Brigham and Women's Hospital/ Harvard Medical School
  BOSTON, MA, United States

  Disclosure information not submitted.
• DI

  David Isenberg, MD, FRCP

  University College London
  London, United Kingdom

  Disclosure information not submitted.

Community Speaker(s)

• MM

  Marta Mosca, MD, PhD

  University of Pisa
  Pisa, Pisa, Italy

  Disclosure information not submitted.

Discussion: Biologic Combinations: Do they have a future for SLE?
Viewpoints: Biologic Combos for Lupus Nephritis by Maria Dall'era, MD